This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John A. Panagopoulos, MD; Paul P. Svitra, MD; Carmen A. Puliafito, MD; Evangelos S. Gragoudas, MD

Arch Ophthalmol. 1989;107(6):886-890.

Abstract
• Chloroaluminum sulfonated phthalocyanine (CASPc), a novel photosensitizing dye, was evaluated for treatment of experimental intraocular melanoma in 33 rabbit eyes. An argon ion pumped dye laser, operating at an emission of 675 nm, was used in a nonthermal mode to irradiate iris tumors in rabbits 24 hours after they received an intravenous dye injection (23 eyes). The effects of laser irradiation alone and dye alone were examined in ten control eyes. A threshold tumoricidal dose was established for photodynamic therapy with CASPc and laser irradiation. Vascular occlusion was produced in a well-circumscribed area corresponding to the boundaries of laser irradiation after CASPc injection. Tumors successfully treated with CASPc and laser irradiation were arrested in growth and exhibited no viable tumor cells on histologic examination. Control tumors continued rapid growth, unaffected by dye or laser. Our data indicate that CASPc demonstrates a strong photosensitizing effect on both tumor and normal tissue. These results suggest that CASPc is a potential photosensitizing compound that may be useful in the treatment of choroidal melanoma.

Author Affiliations
From the Retina Service and the Laser Research Laboratory, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston.

Footnotes
Accepted for publication Nov 22, 1988.

Reprint requests to Laser Research Laboratory, Massachusetts Eye and Ear Infirmary, 243 Charles St, Boston, MA 02114 (Dr Puliafito).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Photodynamic Therapy of Pigmented Choroidal Melanomas Using a Liposomal Preparation of Benzoporphyrin Derivative
Young et al.
Arch Ophthalmol 1996;114:186-192.
ABSTRACT  

Photodynamic Therapy of Experimental Choroidal Neovascularization Using Lipoprotein-Delivered Benzoporphyrin
Miller et al.
Arch Ophthalmol 1995;113:810-818.
ABSTRACT  

Photodynamic Therapy of Experimental Subchoroidal Melanoma Using Chloroaluminum Sulfonated Phthalocyanine
Ozler et al.
Arch Ophthalmol 1992;110:555-561.
ABSTRACT  

Exudative Retinal Detachment After Photodynamic Injury
Wilson et al.
Arch Ophthalmol 1991;109:125-134.
ABSTRACT  

Encircling Photothrombotic Therapy for Choroidal Greene Melanoma Using Rose Bengal
Winward et al.
Arch Ophthalmol 1990;108:588-594.
ABSTRACT